Simultaneously, the combinatorial treatment also showed a significant decrease in the mRNA expressions of pro-inflammatory genes ( TNF- , IL-2 , INF- , TGF- , and VEGF ) known to be involved in the proliferation of cancer cells
Van Hemelrijck M, Jassem W, Walldius G, Fentiman IS, Hammar N, Lambe M, Garmo H, Jungner I, Holmberg L
It is the primary actin-sequestering protein in mammalian cells and has been studied for its role in cell migration, angiogenesis, and tissue repair
human clinical trials ongoing as of 2026 Search volume: 165,000 monthly US searches most searched non-weight-loss peptide Legal status: Category 1 compounding (legal under physician prescription, as of February 2026) Administration: Subcutaneous injection or oral/sublingual (gut applications) An honest note on the evidence: The majority of BPC-157 research has been conducted in animal models rats and mice primarily